check_circleStudy Completed

Contraception, Ovulation Inhibition, Contraceptives, Oral

Bayer Identifier:

90809

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to evaluate efficacy and safety of the oral contraceptive SH T 186 D containing 0.02 mg ethinylestradiol and 3 mg drospirenone in a 21-day regimen

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
516
Trial Dates
August 2000 - April 2003
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Yasminelle (EE20/DRSP, BAY86-5300)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Multi-center, open, uncontrolled study to investigate the efficacy and safety of the oral contraceptive SH T 186 D containing 0.02 mg ethinylestradiol and 3 mg drospirenone in a 21-day regimen for 26 cycles in 504 healthy female subjects
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.